Abiopharma

New Form DEF 14A - SAB Biotherapeutics, Inc. Filed: 2025-08-29 AccNo: 0001193125-25-192856 Size: 1 MB

New Form 10-Q - Celularity Inc Filed: 2025-08-29 AccNo: 0001641172-25-026067 Size: 12 MB

New Form 425 - Gryphon Digital Mining, Inc. Filed: 2025-08-29 AccNo: 0001213900-25-082688 Size: 15 KB

New Form 8-K - Calidi Biotherapeutics, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-026066 Size: 7 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Safety Shot, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-026065 Size: 570 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits

New Form 8-K - Enveric Biosciences, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-026054 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form S-1 - Akari Therapeutics Plc Filed: 2025-08-29 AccNo: 0001641172-25-026052 Size: 1 MB

New Form N-CSR - DAXOR CORP Filed: 2025-08-29 AccNo: 0001641172-25-026053 Size: 387 KB

New Form S-1 - Azitra, Inc. Filed: 2025-08-29 AccNo: 0001493152-25-012495 Size: 1 MB

New Form PRE 14A - Owlet, Inc. Filed: 2025-08-29 AccNo: 0001140361-25-033466 Size: 7 MB

Investor Alert: Robbins LLP Informs Investors that a Class Action Lawsuit Has Been Filed Against Semler Scientific, Inc.

New Form PREM14A - STAAR SURGICAL CO Filed: 2025-08-29 AccNo: 0001193125-25-192889 Size: 1 MB

Biomerica, Inc. - Biomerica Reports Fiscal 2025 Year End Results

Biomerica Reports Fiscal 2025 Year End Results

New Form PRE 14A - Safety Shot, Inc. Filed: 2025-08-29 AccNo: 0001641172-25-026042 Size: 1 MB